MDNC: Medinotec Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 58.67
Enterprise Value ($M) 57.03
Book Value ($M) 2.83
Book Value / Share 0.24
Price / Book 20.76
NCAV ($M) 2.38
NCAV / Share 0.20
Price / NCAV 24.61

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.20
Return on Equity (ROE) 0.38

Liquidity (mrq)
Quick Ratio 2.56
Current Ratio 3.34

Balance Sheet (mrq) ($M)
Current Assets 4.92
Assets 5.36
Liabilities 2.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended November 30, 2024 ☐ Transition Report pursuant to
2024-10-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended August 31, 2024 ☐ Transition Report pursuant to 1
2024-07-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended May 31, 2024 ☐ Transition Report pursuant to 13 o
2024-07-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2024 ☐ TRANSITION REPORT PURSUA

(click for more detail)

Similar Companies
MCAG – Mountain Crest Acquisition Corp. V MDIT – Medite Cancer Diagnostics, Inc.
MDLH – Medical International Technology, Inc. MDRSF – Medartis Holding AG
MEDGF – Medacta Group SA


Financial data and stock pages provided by
Fintel.io